SLC5A5 and thyroid cancer: The hypoxic and quiescent tumor microenvironment inside the spheroids may affect the expression of the sodium/iodide symporter (NIS) in thyroid cancer cells, which in turn affects their radioactive iodine (RAI) uptake and therapeutic efficacy [30].